ArticleClinical and translational medicine2021

Hindering triple negative breast cancer progression by targeting endogenous interleukin-30 requires IFNγ signaling.

Carlo Sorrentino et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.